HUTCHMED (China) Limited
HCM.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | £3 | £3 | £4 | £5 |
| - Cash | £1 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1 | £3 | £3 | £5 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 0% | -14.4% | 0% | – |
| Gross Profit | £0 | £0 | -£0 | -£0 |
| % Margin | 39.7% | 39.7% | -17.4% | -17.4% |
| EBITDA | £0 | £0 | -£0 | -£0 |
| % Margin | 0.9% | 0.9% | -3.1% | -3.1% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 163.8% | 163.8% | 3.7% | 3.7% |
| EPS Diluted | 0.26 | 0.26 | 0.005 | 0.005 |
| % Growth | 0% | 5,100% | 0% | – |
| Operating Cash Flow | -£0 | -£0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | £0 | £0 |